Glenmark Pharmaceuticals has informed that it attached media release titled ‘Glenmark Pharmaceuticals receives ANDA approval for Prochlorperazine Maleate Tablets USP, 5 mg and 10 mg’.
The above information is a part of company’s filings submitted to BSE.